Press releases | WebDisclosure

PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress

AMOEBA Collaboration Market Authorization Biofungicide US EPA
PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

AMOEBA prépare le lancement commercial de la gamme AXPERA aux États-Unis grâce à l'homologation attendue en 2025
Amoéba annonce la recevabilité du dossier d'homologation de ses produits de biocontrôle aux États-Unis par l'US EPA et le dépôt d'une demande d'AMM pour ses biofongicides AXPERA GREEN et AXPERA NOA

AMOEBA Biocontrôle Homologation US EPA Biofongicides
PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

RACHAT D'ACTIONS PROPRES
Roche Bobois SA annonce les détails du programme de rachat d'actions propres autorisé en 2023, incluant les transactions du 19 au 23 août 2024

Rachat D'actions Transactions Euronext Informations Financières Roche Bobois SA
REGULATED PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

Disclosure of trading in own shares from August 19th, 2024, to August 23th, 2024. Detailed information per transaction
REGULATED PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

Déclaration des transactions sur actions propres réalisées du 19 août 2024 au 23 août 2024. Présentation détaillée transaction par transaction
REGULATED PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

Disclosure of trading in own shares from August 19th, 2024, to August 23th, 2024.
Lagardère SA reports trading in own shares from August 19th-23rd, 2024, as per regulatory requirement. More details on www.lagardere.com Investor Relations

Lagardère SA Investor Relations Trading Own Shares Regulatory Disclosure
REGULATED PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

Déclaration des transactions sur actions propres réalisées Du 19 août 2024 au 23 août 2024.
Déclaration des transactions sur actions propres de Lagardère SA du 19/08/2024 au 23/08/2024 conformément à la réglementation. Les détails sont disponibles sur www.lagardere.com

Actions Propres Déclaration Transactions Lagardère SA Réglementation
PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

Inside Information / News release on accounts, results
ID Logistics reports strong financial performance in H1 2024, with revenues up 18.7% to €1,518.6m and underlying operating income up 22.7% to €58.3m. Chairman Eric Hémar reflects on efficient growth management

Revenues Financial Performance Operating Income ID Logistics H1 2024
REGULATED PRESS RELEASE

published on 08/28/2024 at 17:40, 1 year 8 months ago

Résultats du 1er semestre 2024
REGULATED PRESS RELEASE

published on 08/28/2024 at 17:40, 1 year 8 months ago

2024 half-year results
Eiffage reports +6.3% revenue growth and solid earnings performance in 2024 first-half results, with positive outlook and sustainability commitments

Eiffage Revenue Growth Sustainability Earnings Performance 2024 First-half Results

Published on 05/09/2026 at 01:55, 5 hours 16 minutes ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 5 hours 31 minutes ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 5 hours 41 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 7 hours 11 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 8 hours 10 minutes ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

Published on 05/08/2026 at 20:38, 10 hours 32 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 11 hours 58 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 12 hours 8 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 12 hours 41 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:29, 12 hours 41 minutes ago

Designated Person Notification

View all EQS

Published on 05/07/2026 at 19:15, 1 day 11 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 11 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 12 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 12 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 12 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

News